NCT03213743View on ClinicalTrials.gov

Expression Profiling of microRNA Following Administration of Dexmedetomidine

NACompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

June 19, 2017

Primary Completion Date

June 21, 2017

Study Completion Date

June 21, 2017

Conditions
Coronary Disease
Interventions
DRUG

Dexmedetomidine Injection

Investigators gave the patients loading dose of dexmedetomidine for 10 minutes and maintaining dose of dexmedetomidine for 20 minutes. Investigators took blood samples before and after the administration of dexmedetomidine.

Trial Locations (1)

650032

Jinqiao Qian, Kunming

All Listed Sponsors
lead

First Affiliated Hospital of Kunming Medical University

OTHER

NCT03213743 - Expression Profiling of microRNA Following Administration of Dexmedetomidine | Biotech Hunter | Biotech Hunter